Resveratrol ameliorates ulcerative colitis by upregulating Nrf2/HO ‑1 pathway activity: Integrating animal experiments and network pharmacology

In conclusion, Res treatment activated the Nrf2/HO‑1 pathway to decrease clinical symptoms, inflammatory responses, and intestinal mucosal barrier damage in experimental UC mice.PMID:38488031 | DOI:10.3892/mmr.2024.13201
Source: Molecular Medicine Reports - Category: Molecular Biology Authors: Source Type: research